443 related articles for article (PubMed ID: 17016226)
1. Tumor necrosis has no prognostic value in neoadjuvant chemotherapy for soft tissue sarcoma.
Menendez LR; Ahlmann ER; Savage K; Cluck M; Fedenko AN
Clin Orthop Relat Res; 2007 Feb; 455():219-24. PubMed ID: 17016226
[TBL] [Abstract][Full Text] [Related]
2. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
[TBL] [Abstract][Full Text] [Related]
3. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.
Noorda EM; Vrouenraets BC; Nieweg OE; van Coevorden F; van Slooten GW; Kroon BB
Cancer; 2003 Oct; 98(7):1483-90. PubMed ID: 14508836
[TBL] [Abstract][Full Text] [Related]
4. Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation.
Lucas DR; Kshirsagar MP; Biermann JS; Hamre MR; Thomas DG; Schuetze SM; Baker LH
Oncologist; 2008 Apr; 13(4):451-8. PubMed ID: 18448561
[TBL] [Abstract][Full Text] [Related]
5. Cryoablation and resection influences patient survival for soft tissue sarcomas: impact on survivorship and local recurrence.
Ahlmann ER; Falkinstein Y; Fedenko AN; Menendez LR
Clin Orthop Relat Res; 2007 Jun; 459():174-81. PubMed ID: 17415009
[TBL] [Abstract][Full Text] [Related]
6. [The effects of surgical margins on local control and survival in extremity soft tissue sarcomas].
Yildiz C; Erler K; Bilgiç S; Ateşalp AS; Başbozkurt M
Acta Orthop Traumatol Turc; 2003; 37(5):359-67. PubMed ID: 14963391
[TBL] [Abstract][Full Text] [Related]
7. Limb salvage surgery in combination with brachytherapy and external beam radiation for high-grade soft tissue sarcomas.
Beltrami G; Rüdiger HA; Mela MM; Scoccianti G; Livi L; Franchi A; Campanacci DA; Capanna R
Eur J Surg Oncol; 2008 Jul; 34(7):811-6. PubMed ID: 17981427
[TBL] [Abstract][Full Text] [Related]
8. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma.
Vaynrub M; Taheri N; Ahlmann ER; Yao C; Fedenko AN; Allison DC; Chawla SP; Menendez LR
J Surg Oncol; 2015 Feb; 111(2):152-7. PubMed ID: 25175933
[TBL] [Abstract][Full Text] [Related]
10. Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas.
Meric F; Hess KR; Varma DG; Hunt KK; Pisters PW; Milas KM; Patel SR; Benjamin RS; Plager C; Papadopoulos NE; Burgess MA; Pollock RE; Feig BW
Cancer; 2002 Sep; 95(5):1120-6. PubMed ID: 12209699
[TBL] [Abstract][Full Text] [Related]
11. Outcome after surgical resections of recurrent chest wall sarcomas.
Wouters MW; van Geel AN; Nieuwenhuis L; van Tinteren H; Verhoef C; van Coevorden F; Klomp HM
J Clin Oncol; 2008 Nov; 26(31):5113-8. PubMed ID: 18794540
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk.
Hasegawa T; Yamamoto S; Yokoyama R; Umeda T; Matsuno Y; Hirohashi S
Cancer; 2002 Aug; 95(4):843-51. PubMed ID: 12209729
[TBL] [Abstract][Full Text] [Related]
13. Preoperative chemoradiotherapy (modified Eilber protocol) provides maximum local control and minimal morbidity in patients with soft tissue sarcoma.
Mack LA; Crowe PJ; Yang JL; Schachar NS; Morris DG; Kurien EC; Temple CL; Lindsay RL; Magi E; DeHaas WG; Temple WJ
Ann Surg Oncol; 2005 Aug; 12(8):646-53. PubMed ID: 15965732
[TBL] [Abstract][Full Text] [Related]
14. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
[TBL] [Abstract][Full Text] [Related]
15. [Treatment and prognosis of soft tissue sarcoma].
Wang Y; Shen Z; Zhang R
Zhonghua Wai Ke Za Zhi; 1996 Jan; 34(1):29-32. PubMed ID: 9275684
[TBL] [Abstract][Full Text] [Related]
16. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy.
Thijssens KM; van Ginkel RJ; Pras E; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2006 Apr; 13(4):518-24. PubMed ID: 16485147
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996).
Kuntz CA; Dernell WS; Powers BE; Devitt C; Straw RC; Withrow SJ
J Am Vet Med Assoc; 1997 Nov; 211(9):1147-51. PubMed ID: 9364229
[TBL] [Abstract][Full Text] [Related]
18. Surgical management of soft tissue sarcomas of the hand and foot.
Lin PP; Guzel VB; Pisters PW; Zagars GK; Weber KL; Feig BW; Pollock RE; Yasko AW
Cancer; 2002 Aug; 95(4):852-61. PubMed ID: 12209730
[TBL] [Abstract][Full Text] [Related]
19. Preoperative isolated limb infusion of Doxorubicin and external irradiation for limb-threatening soft tissue sarcomas.
Hegazy MA; Kotb SZ; Sakr H; El Dosoky E; Amer T; Hegazi RA; Farouk O
Ann Surg Oncol; 2007 Feb; 14(2):568-76. PubMed ID: 17094027
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy of soft tissue sarcomas in the extremities.
Sudo A; Fujinami S; Shiokawa Y; Ogihara Y
Jpn J Clin Oncol; 1991 Oct; 21(5):346-52. PubMed ID: 1753415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
